Patient survival after renal transplantation III: the effects of statins.
about
HMG CoA reductase inhibitors (statins) for kidney transplant recipientsHMG CoA reductase inhibitors (statins) for kidney transplant recipientsPost-transplant dyslipidemia: Mechanisms, diagnosis and managementHMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survivalDeath with functioning kidney transplant: an obituarial analysisPrevalence of modifiable cardiovascular risk factors in long-term renal transplant patients.Potential nontraditional applications of statins.Worsening of hyperglycemia due to atorvastatin in a renal transplant patient.Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.Guidelines for the treatment and management of new-onset diabetes after transplantation.Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.Statin use is associated with prolonged survival of renal transplant recipients.Does African American Race Impact Statin Efficacy in Renal Transplant Outcomes?Effects of statin treatment in patients with coronary artery disease and chronic kidney diseasefluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study.Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins).Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus.Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation.Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation.Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation.
P2860
Q24200984-4858AD0B-6735-4D87-8260-2EAE15A51060Q24241098-E97FE454-6D74-4492-A678-F8DF07BA468CQ28076119-B858791D-E57A-4A24-9589-E016F560EB11Q33548525-7C3A46EB-4997-4139-A737-A067F674B72AQ34368831-64FDA597-D816-4225-916C-269B14665F02Q35026687-E46A541F-9FD4-4DC7-8C13-7AEA51A49FCDQ35169445-3B7FE601-F87B-4A83-89F4-F04258D1C4DBQ35573997-06B268CA-96F5-4C78-A0E5-2C7B7647C61BQ36073213-B2B931C3-0523-4D0B-9C16-A717C10B7A11Q36118632-40719FDB-232F-4D86-89C4-19CABCE95932Q36288839-980887AF-D6F6-480C-AB30-BA39C595F604Q36949237-48D48E6E-F2B1-47BE-94A7-8E28A9DE4312Q37226086-9F186606-C3AA-44C7-9D82-17B5EE2AF8ADQ37471756-628AF828-3B33-47C6-862A-CCFD0E1122B6Q44899028-E210087A-7D57-4657-83F0-9FBCE711C606Q45100330-EF10B284-6B45-4CF2-9A07-6417FED5CBA6Q46398322-F14D7749-94E6-4841-BDC6-D6B046CBCC00Q46645985-203C984F-B0DD-4BAD-8FD6-485ED580FC5FQ46885124-44F74416-6EC2-48F6-A004-C95BC86F202DQ46909286-4C473651-8826-4916-A639-DA10BBDD0A81Q47106229-05885CD4-7DF4-4D7B-B9F3-C847F2787B5F
P2860
Patient survival after renal transplantation III: the effects of statins.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Patient survival after renal transplantation III: the effects of statins.
@en
Patient survival after renal transplantation III: the effects of statins.
@nl
type
label
Patient survival after renal transplantation III: the effects of statins.
@en
Patient survival after renal transplantation III: the effects of statins.
@nl
prefLabel
Patient survival after renal transplantation III: the effects of statins.
@en
Patient survival after renal transplantation III: the effects of statins.
@nl
P2093
P356
P1476
Patient survival after renal transplantation III: the effects of statins.
@en
P2093
Fernando G Cosio
Mitchell Henry
Ronald M Ferguson
Ronald P Pelletier
Stanley Lemeshow
Todd E Pesavento
P304
P356
10.1053/AJKD.2002.34927
P577
2002-09-01T00:00:00Z